The group’s principal activity is to built a toxicology database to help drugmakers analyze potential drug candidates and possible drug combinations. The DrugMatrix database consists of information on chemical compounds and genomics data. The group’s Drug Signatures library includes genomic biomarkers that help predict toxicological outcomes. The group also offers contract toxicogenomics research services. The group operates from the United States.
